The Enterprise Value as of December 2025 (TTM) for Pharmosa Biopharm Inc. (6875.TWO) is 6.18B

According to Pharmosa Biopharm Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 6.18B. This represents a change of 1.64% compared to the average of 6.08B of the last 4 quarters.

Pharmosa Biopharm Inc. (6875.TWO) Historical Enterprise Value (quarterly & annually)

How has 6875.TWO Enterprise Value performed in the past?

The mean historical Enterprise Value of Pharmosa Biopharm Inc. over the last ten years is 5.53B. The current 6.18B Enterprise Value has changed 11.09% with respect to the historical average. Over the past ten years (40 quarters), 6875.TWO's Enterprise Value was at its highest in in the June 2023 quarter at 12.26B. The Enterprise Value was at its lowest in in the September 2022 quarter at 0.

Pharmosa Biopharm Inc. (6875.TWO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Pharmosa Biopharm Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Pharmosa Biopharm Inc. (6875.TWO) Average Enterprise Value

How has 6875.TWO Enterprise Value performed in the past?

The current Enterprise Value of Pharmosa Biopharm Inc. (6875.TWO) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Pharmosa Biopharm Inc. (6875.TWO) Enterprise Value vs. Peers

How is 6875.TWO’s Enterprise Value compared to its peers?

Pharmosa Biopharm Inc.’s Enterprise Value is less than TaiGen Biopharmaceuticals Holdings Limited (8.09B), less than Mycenax Biotech Inc. (7.51B), less than OBI Pharma, Inc. (6.99B), less than CHO Pharma, Inc. (6.48B), less than Sinphar Pharmaceutical Co.,Ltd. (6.61B), less than Adimmune Corporation (9.19B), greater than BioGend Therapeutics Co., Ltd. (4.66B), greater than Panion & Bf Biotech Inc. (5.87B), greater than Savior Lifetec Corporation (4.71B), less than Locus Cell Co., Ltd. (0),

Build a custom stock screener for Pharmosa Biopharm Inc. (6875.TWO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Pharmosa Biopharm Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Pharmosa Biopharm Inc. (6875.TWO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Pharmosa Biopharm Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.